[Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology]

Gac Med Mex. Jan-Feb 2009;145(1):41-9.
[Article in Spanish]

Abstract

We describe the guidelines for the current treatment of ankylosing spondylitis with an emphasis on the role and outlook of the Mexican rheumatologic community. The topics we analyze include: epidemiological as well as professional, financial, health status, and quality of life aspects. We propose to acknowledge that axial spondyloarthritis is the earliest form of ankylosing spondylitis. Finally we carry out a review of the literature supporting current therapeutic recommendations. Regarding the latter, we approached the ASAS/EULAR recommendations for the treatment of ankylosing spondylitis and their level of agreement with Mexican and other countries' rheumatologists. Finally, we analyzed the recommendations to start tumor necrosis alpha blockers among patients with ankylosing spondylitis.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Mexico
  • Practice Guidelines as Topic*
  • Rheumatology
  • Spondylitis, Ankylosing / therapy*